Interleukin-10 levels are often elevated in serum of adults with Hodgkin's disease and are associated with inferior failure-free survival
Open Access
- 1 April 1999
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 10 (4) , 433-440
- https://doi.org/10.1023/a:1008301602785
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- A Prognostic Score for Advanced Hodgkin's DiseaseNew England Journal of Medicine, 1998
- Prognostic Factors in Advanced Hodgkin's Disease: Problems and Pitfalls. Towards an International Prognostic IndexLeukemia & Lymphoma, 1995
- Epstein-Barr virus and childhood Hodgkin's disease in Honduras and the United StatesBlood, 1993
- High prevalence of Epstein-Barr virus in the Reed-Sternberg cells of Hodgkin's disease occurring in PeruBlood, 1993
- Epstein–Barr virus (EBV) and Hodgkin's disease in children: Incidence of EBV latent membrane protein in malignant cellsThe Journal of Pathology, 1992
- Chemotherapy of Advanced Hodgkin's Disease with MOPP, ABVD, or MOPP Alternating with ABVDNew England Journal of Medicine, 1992
- A Numerical Prognostic Index for Clinical use in Identification of Poor-Risk Patients with Hodgkin's Disease at DiagnosisLeukemia & Lymphoma, 1992
- Prognostic factors among 185 adults with newly diagnosed advanced Hodgkin's disease treated with alternating potentially noncross-resistant chemotherapy and intermediate-dose radiation therapy.Journal of Clinical Oncology, 1990
- Demonstration of monoclonal EBV genomes in Hodgkin's disease and Ki-1- positive anaplastic large cell lymphoma by combined Southern blot and in situ hybridization [see comments]Blood, 1989
- Twenty years of MOPP therapy for Hodgkin's disease.Journal of Clinical Oncology, 1986